Objective The effect of moderate excess alcohol consumption is widely debated and has not been well defined in dilated cardiomyopathy (DCM). There is need for a greater evidence base to help advise ...

Background: Symptoms are among the most important factors impacting quality of life (QOL) in hypertrophic cardiomyopathy (HCM) patients, and reflect a poor prognosis. Whether emotional stress can ...

Dry January, initiated by Alcohol Change UK, promotes abstaining from alcohol for the month of January, resulting in improved ...

The survey queried demographic and self-reported clinical information, as well as information regarding presence of symptoms (fainting/syncope, near-syncope, or lightheadedness; [grouped for ...

After a month of sobriety with Dry January, many are embracing Wet February, leading to increased alcohol consumption.

Fortunately, non-alcoholic whiskey has come a long way, providing a sophisticated option for those embracing a dry month (or two) and all mocktail enthusiasts. I tested six of the best non ...

Non-communicable diseases represent the primary cause of mortality and morbidity globally, accounting for 74% of all deaths and more than three-quarters of years lived with disability. Here, we ...

Mavacamten is a first-in-class cardiac myosin ATPase inhibitor, approved by the United States Food and Drug Administration for the treatment of hypertrophic cardiomyopathy with obstructive physiology ...